Cooper Companies (NYSE:COO) had its target price trimmed by KeyCorp from $298.00 to $296.00 in a research report sent to investors on Friday morning. The firm currently has an overweight rating on the medical device company’s stock. KeyCorp also issued estimates for Cooper Companies’ Q1 2019 earnings at $2.69 EPS, Q1 2019 earnings at $2.42 EPS, Q2 2019 earnings at $2.82 EPS, Q2 2019 earnings at $2.97 EPS, Q3 2019 earnings at $3.17 EPS, Q3 2019 earnings at $3.18 EPS, Q4 2019 earnings at $3.14 EPS, Q4 2019 earnings at $3.23 EPS, FY2019 earnings at $11.57 EPS, FY2019 earnings at $12.05 EPS, FY2020 earnings at $13.89 EPS and FY2020 earnings at $13.45 EPS.

Other analysts have also issued reports about the stock. Zacks Investment Research upgraded shares of Cooper Companies from a sell rating to a hold rating in a research note on Monday, October 1st. Raymond James upped their target price on shares of Cooper Companies from $270.00 to $300.00 and gave the stock an outperform rating in a research note on Friday, September 21st. Wells Fargo & Co upped their target price on shares of Cooper Companies from $290.00 to $295.00 and gave the stock an outperform rating in a research note on Monday, November 12th. ValuEngine upgraded shares of Cooper Companies from a hold rating to a buy rating in a research note on Thursday, September 27th. Finally, BMO Capital Markets upped their target price on shares of Cooper Companies from $280.00 to $285.00 and gave the stock an outperform rating in a research note on Friday, August 31st. Five research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Cooper Companies has a consensus rating of Buy and an average price target of $284.50.

Shares of COO stock traded down $34.02 during trading hours on Friday, reaching $243.01. 1,253,678 shares of the stock were exchanged, compared to its average volume of 333,174. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.54 and a current ratio of 2.58. Cooper Companies has a 12-month low of $216.47 and a 12-month high of $283.18. The firm has a market capitalization of $13.61 billion, a price-to-earnings ratio of 21.13, a PEG ratio of 2.13 and a beta of 0.77.

Cooper Companies (NYSE:COO) last released its earnings results on Thursday, December 6th. The medical device company reported $2.87 earnings per share for the quarter, missing the Zacks’ consensus estimate of $2.96 by ($0.09). Cooper Companies had a return on equity of 17.86% and a net margin of 5.52%. The firm had revenue of $651.50 million for the quarter, compared to analysts’ expectations of $645.25 million. During the same quarter in the previous year, the company posted $2.65 earnings per share. The firm’s quarterly revenue was up 16.0% on a year-over-year basis. Equities analysts forecast that Cooper Companies will post 12.1 EPS for the current fiscal year.

In other Cooper Companies news, COO Daniel G. Mcbride sold 10,310 shares of the stock in a transaction that occurred on Thursday, September 13th. The shares were sold at an average price of $264.44, for a total value of $2,726,376.40. Following the transaction, the chief operating officer now directly owns 38,705 shares in the company, valued at $10,235,150.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Allan E. Rubenstein sold 1,500 shares of the stock in a transaction that occurred on Thursday, September 13th. The shares were sold at an average price of $265.37, for a total transaction of $398,055.00. Following the completion of the transaction, the director now owns 3,068 shares in the company, valued at $814,155.16. The disclosure for this sale can be found here. Insiders sold 20,691 shares of company stock worth $5,527,869 over the last quarter. 1.60% of the stock is currently owned by insiders.

A number of institutional investors have recently made changes to their positions in the business. Findlay Park Partners LLP grew its position in shares of Cooper Companies by 225.0% during the third quarter. Findlay Park Partners LLP now owns 738,824 shares of the medical device company’s stock worth $204,765,000 after acquiring an additional 511,518 shares during the last quarter. Janus Henderson Group PLC grew its position in shares of Cooper Companies by 23.8% during the second quarter. Janus Henderson Group PLC now owns 2,618,690 shares of the medical device company’s stock worth $616,595,000 after acquiring an additional 502,783 shares during the last quarter. Putnam Investments LLC grew its position in shares of Cooper Companies by 228.5% during the third quarter. Putnam Investments LLC now owns 622,865 shares of the medical device company’s stock worth $172,627,000 after acquiring an additional 433,242 shares during the last quarter. Morgan Stanley grew its position in shares of Cooper Companies by 734.7% during the third quarter. Morgan Stanley now owns 177,658 shares of the medical device company’s stock worth $49,238,000 after acquiring an additional 156,373 shares during the last quarter. Finally, Marshall Wace North America L.P. grew its position in shares of Cooper Companies by 875.3% during the third quarter. Marshall Wace North America L.P. now owns 144,900 shares of the medical device company’s stock worth $40,159,000 after acquiring an additional 130,043 shares during the last quarter.

About Cooper Companies

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Further Reading: Penny Stocks, What You Need To Know

Analyst Recommendations for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.